Mark Hazeltine, Exagen Inc.'s Chief Operating Officer, recently acquired 1,934 shares of the company. The buys took place at $0.26 per share, on May 17, 2021. Hazeltine now owns 39,434 shares of the company. Hazeltine operates out of Vista, CA. Some additional info was provided as follows:
The option is exercisable as it vests. 25% of the shares subject to the option vested on October 5, 2019, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Exagen Inc. makes a similar move, sign up!